Royal Bank Of Canada Keros Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 11,256 shares of KROS stock, worth $116,161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,256
Previous 4,726
138.17%
Holding current value
$116,161
Previous $274,000
35.04%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KROS
# of Institutions
172Shares Held
29.9MCall Options Held
341KPut Options Held
102K-
Black Rock Inc. New York, NY2.51MShares$25.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$20.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$19.6 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$17.4 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$12.4 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $266M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...